COMMUNIQUÉS West-GlobeNewswire

Spineway : 2024 revenue of €12 million - 14% growth compared with 2023
22/01/2025
Press release Ecully, January 22, 2025 – 6.30 p.m. SPINEWAY 2024 revenue of €12 million 14% growth compared with 2023 In thousands of euros 2024 2023 Change as a % H1 revenue 6,535 5,431 +20% H2 revenue 5,415 5,088 +6% [...]
Spineway : Chiffre d’affaires annuel 2024 de 12 M€ - Croissance de 14% par rapport à 2023
22/01/2025
Communiqué de presse Ecully, le 22 janvier 2025 –18h30 SPINEWAY Chiffre d’affaires annuel 2024 de 12 M€ Croissance de 14% par rapport à 2023 En milliers d’euros 2024 2023 Variation en % CA 1 er semestre 6 535 5 431 + 20 [...]
Valneva Reports Positive Phase 2 Results in Children for its Chikungunya Vaccine and Announces Phase 3 Dose Decision
22/01/2025
Saint-Herblain (France), January 22, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced positive results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose [...]
Valneva annonce des résultats de Phase 2 positifs chez les enfants pour son vaccin contre le chikungunya ainsi que la dose sélectionnée pour la Phase 3
22/01/2025
Saint-Herblain (France), le 22 janvier 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), société spécialisée dans les vaccins, a annoncé aujourd’hui des résultats positifs pour son étude clinique de Phase 2 [...]
Adam Ferrari Announces Annie O’Brien as the 2024 Recipient of the Adam Ferrari Health Science Scholarship
22/01/2025
Adam Ferrari proudly announces Annie O’Brien, a nursing student at Marquette University, as the 2024 Adam Ferrari Health Science Scholarship recipient. DENVER, Jan. 22, 2025 (GLOBE NEWSWIRE) -- The Ferrari Foundation is [...]
Dr. Todd Cevene Reveals Breakthrough in Metabolic Science for Sustainable Weight Loss
22/01/2025
Dr. Todd Cevene's revolutionary metabolic science approach offers a unique, non-restrictive path to sustainable weight loss Rockford, Illinois, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Dr. Todd Cevene, creator of the "Secret [...]
Outlook Therapeutics® to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
22/01/2025
Live webcast on Wednesday, January 29th at 2:00 PM ET ISELIN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the [...]
Altamira Therapeutics Announces Collaboration on Radiopharmaceutical Targeting Strategies
22/01/2025
Hamilton, Bermuda, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Exploring use of Altamira’s RNA nanoparticles in conjunction with radiopharmaceutical cancer treatment Project collaboration partner will have option to negotiate [...]
Bioxytran Secures $1.6 million SPA to Extinguish Note & Fund Clinical Development
22/01/2025
- Repurchasing all convertible note overhang, and - Funding pre-clinical and clinical trials - Management forfeiting $460,000 in accrued payroll BOSTON, MASSACHUSETTS, Jan. 22, 2025 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. ( [...]
NeuroSigma Announces Patent Application Protecting Use of Trigeminal Nerve Stimulation to Include Treatment of Dyslexia and Other Neurodevelopmental Disorders
22/01/2025
LOS ANGELES, Jan. 22, 2025 (GLOBE NEWSWIRE) -- NeuroSigma, Inc. , a Los Angeles-based bioelectronics company commercializing the Monarch external Trigeminal Nerve Stimulation (eTNS) device for treating ADHD , today [...]
NEXGEL Issues Letter to Shareholders and Provides Guidance for 2024 and 2025
22/01/2025
Management expects 2024 fourth quarter revenue of approximately $3.0 million and full year 2024 of approximately $8.6 million, representing growth year-over-year of over 100% for the third consecutive year Management [...]
HTM College Education: AAMI Sets New Standard
22/01/2025
First-ever standard for training biomedical, clinical engineers Arlington, Virginia, Jan. 22, 2025 (GLOBE NEWSWIRE) -- There are relatively few healthcare technology management (HTM) educational programs that align with [...]
Sonnet BioTherapeutics to Present at LIVE! with Webull Corporate Connect: Healthcare Investment Webinar
22/01/2025
Live webcast on Wednesday, January 29 th at 2:40 PM ET PRINCETON, NJ, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (the “Company” or “Sonnet”) (NASDAQ: SONN), a clinical-stage company [...]
Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer
22/01/2025
January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage [...]
AIM ImmunoTech Highlights New Article Finding Links Between COVID-19 and ME/CFS
22/01/2025
Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFS The early-onset broad-spectrum antiviral effect of Ampligen has been [...]
Scorpius Holdings Announces Collaboration with KaloCyte to Advance Manufacturing for ErythroMer™
22/01/2025
Partnership highlights Scorpius’ expertise in supporting innovative therapeutic programs DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an [...]
Silo Pharma Advances Intellectual Property Portfolio with Provisional Patent Filing for PTSD Treatment
22/01/2025
SARASOTA, FL, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today [...]
Tiny Health Launches Index Predicting Child’s Gut Microbiome Age
22/01/2025
AUSTIN, Texas, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Tiny Health , a leader in at-home gut microbiome testing, today announced the launch of its Gut Maturation Index, an advanced machine learning tool that predicts a child’ [...]
OrthoPediatrics Corp. Announces Distribution Agreement with Thrive Orthopedics LLC
22/01/2025
WARSAW, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics” or the “Company”) (Nasdaq: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, announced today [...]

Pages